FALLS CHURCH, Va., Aug. 3 /PRNewswire/ -- FDAnews announces the final agenda for the Second Annual FDA Regulatory and Compliance Symposium (http://www.fdasymposium.com), the industry’s leading regulatory and compliance event for the drug and medical device industries, to be held August 22-25 on the campus of Harvard University, Cambridge, MA.
“Regulatory, compliance, quality assurance, manufacturing, clinical trial, reimbursement and marketing professionals need to stay abreast of the critical issues facing the industry, said Matt Salt, publisher of FDAnews, cosponsor of the event. “This Symposium is the best way to meet key FDA officials and industry’s top regulatory and compliance professionals and attend interactive sessions that explore the latest developments in the drug and medical device industries.”
The Second Annual FDA Regulatory and Compliance Symposium will help drug and device makers prepare for the full impact of changes flowing from the FDA and Congress, while clarifying many of the uncertainties. The Symposium will also provide practical, state-of-the-art solutions to the challenges of eliminating or reducing risks throughout the product life cycle -- from the drug pipeline to manufacturing to patient delivery.
Government keynote speakers for this year’s Symposium include: * Thomas Abrams, RPh, MBA, Director, Division of Drug Marketing, Advertising, and Communications, CDER, FDA * Peter Bach, MD, MAPP, Senior Advisor, Office of the Administrator, CMS * Sheldon Bradshaw, Esq., Chief Counsel, FDA * Igor Cerny, Pharm.D., Director, CDER Advisors and Consultants Staff, Office of Executive Programs, FDA * Jon Clark, Associate Director for Policy Development and GMP, Office of Pharmaceutical Science, CDER, FDA * Kim Colangelo, Associate Director for Regulatory Affairs, Office of New Drugs, CDER, FDA * Scott Gottlieb, MD; Deputy Commissioner for Medical and Scientific Affairs, Office of the Commissioner, FDA * David Horowitz, Esq., Deputy Associate Commissioner for Compliance Policy, Office of Regulatory Affairs, FDA * Steve Phurrough, MD, MPA, Director, Coverage and Analysis Group, Office of Clinical Standards & Quality, CMS * CAPT Paul Seligman, MD, MPH, Associate Director for Safety Policy and Communication, CDER, FDA * James Sheehan, Esq., Associate United States Attorney, U.S. Attorney’s Office for the Eastern District of Pennsylvania * David Waterbury, Esq., Senior Counsel and Director, Washington State Medicaid Fraud Control Unit
The Symposium also includes more than 49 expert speakers from business and academia who will discuss regulatory and compliance topics in five separate tracks. In addition, there will be a pre-conference workshop and networking sessions.
The Symposium is on the Harvard University campus. Classes are in Annenberg Hall of the Sanders Theatre Complex.
The FDA Regulatory and Compliance Symposium is sponsored by FDAnews, Harvard Health Policy Review, Health Affairs and Medical Education Collaborative.
Contact:
800-684-4549
FDAnews
CONTACT: Jeff Grizzel, Conference Director of FDAnews, +1-703-538-7668,jgrizzel@fdanews.com
Web site: http://www.fdasymposium.com/
